Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Farag Kameel D.
Over the trailing 90 days, Farag Kameel D. (Other Officer at Akari Therapeutics Plc) bought $105K of stock in AKTX, per 7 SEC Form 4 transactions.
- Role
- Other Officer
- Companies
- AKTX
- Window
- Trailing 90 days · 7 transactions · CIK 2093620
- Net activity
- +$105K ($105K bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| AKTX | Akari Therapeutics Plc | 7 | $105K | — | $105K |
Transactions (7)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-24 | AKTX | Buy | 1.0K | $13K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 7.4K | $28K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 3.7K | $13K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 2.5K | $13K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 1.6K | $13K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 1.4K | $13K | Grant, award or other acquisition |
| 2026-06-24 | AKTX | Buy | 1.2K | $13K | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Farag's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.